Lifeboat Foundation

Find out how endocrine disrupting chemicals, like BPA, can render most men sterile by 2045. Learn about chemicals in our food that disrupt our immune system, about cancer causing chemical in hand sanitizers. See what these have to do with sperm counts falling. How do they affect wildlife, and food production. See what you can do about it!

Green Gregs has teamed up with True Leaf Market to bring you a great selection of seed for your spring planting. Check it out: http://www.pntrac.com/t/TUJGRklGSkJGTU1IS0hCRkpIRk1K

Continue reading “Men to Be Sterile by 2045 — Escape Chemicals to Thrive” »

“A new research study conducted by the Department of Psychiatry & Behavioral Sciences aims to evaluate how visual perception changes after taking psilocybin (aka ”magic mushrooms”) and how these changes relate to brain functions. We might learn how this drug could be used to treat certain mental health conditions. That is why it is essential to have more research to expand our knowledge base about the drug, psilocybin.

Our participants will be healthy adults from ages 25 to 65 years who have taken psilocybin previously. Study duration for participants will be 12 weeks. Over the course of 7 study visits, participants will undergo interviews, MRls, EEG, blood draws, and drug dosing sessions. Participants will be compensated after each visit.

In a head-to-head comparison against a leading treatment for malnutrition, a new supplement designed to promote helpful gut bacteria led to signs of improved growth and more weight gain, despite having 20% fewer calories.

New treatment gets starving children on the right growth trajectory.

Long article, good history, and a warning.

Biotech startups are trying to hack the process of aging and, in the process, stave off the most devastating diseases.

The new AI tool, developed by researchers at Stanford and Genenetech, runs simulated clinical trials using different eligibility criteria.

Like something straight out of a pulpy sci-fi horror flick, researchers at Tufts University and the University of Vermont (UVM) have engineered a new generation of living robots they call Xenobots, which demonstrate cooperative swarm activity while collecting piles of micro particles.

Last year, this same team of scientists and biologists created tiny self-healing bio-machines that exhibited movement, payload pushing abilities, and a sort of hive mentality. The blueprints for creating these biological bots, which technically aren’t a typical robot or a catalogued animal species, but instead are more akin to a distinct class of unique artifact that acts as a living, programmable organism.

Bay Area-based Rapid Robotics today announced a $12 million Series A. The new round, led by NEA, brings the company’s total funding up to $17.5 million. It joins a recently closed seed round, announced way back in November of last year. Existing investors Greycroft, Bee Partners and 468 Capital also took part in the round.

We noted at that stage that COVID-19 had a sizable impact on robotics investment. At the very least, the pandemic has served to accelerate interest in automation, as many “non-essential” workers have been unable to travel to their jobs. At present, manufacturing jobs often lack the ability to perform remotely.

Rapid notes that the company’s tech has been involved with the production of some 50 million parts over the past year, over a wide variety of different manufacturing verticals. And, like his predecessor, President Biden has already begun talking up strategies to return manufacturing jobs to the U.S. Of course, ambitious as it might be, any plan is going to have to be a balancing act between human jobs and automation.

Summary: Combining artificial intelligence technology with brain scan data, researchers have identified three novel subtypes of multiple sclerosis.

Source: UCL

Scientists at UCL have used artificial intelligence (AI) to identify three new multiple sclerosis (MS) subtypes. Researchers say the groundbreaking findings will help identify those people more likely to have disease progression and help target treatments more effectively.

Delaying, Detecting, Preventing and Treating Aging And Associated Diseases — Dr. Brian Kennedy, Ph.D., National University of Singapore.

Dr. Brian Kennedy is Distinguished Professor, Department of Biochemistry and Physiology, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Director of National University Health System (NUHS) Centre for Healthy Ageing, Singapore, Professor, Buck Institute for Research on Ageing, Adjunct Professor, Leonard Davis School of Gerontology, USC, and Affiliate Faculty, Department of Biochemistry, University of Washington.

Continue reading “Dr. Brian Kennedy Ph.D. — Delaying, Detecting, Preventing and Treating Aging And Associated Diseases” »